Yahoo Finance Wall St falls sharply on worries about banks
Wall Street dropped on Thursday, weighed down by Apple as well as selling in Wells Fargo, Citigroup and other major banks as investors worried about the health of Deutsche Bank. Bobbi Rebell reports.
Wall Street dropped on Thursday, weighed down by Apple as well as selling in Wells Fargo, Citigroup and other major banks as investors worried about the health of Deutsche Bank. Bobbi Rebell reports.
U.S. economic growth slowed more than expected in the first quarter, but an acceleration in inflation suggested that the Federal Reserve would not cut interest rates before September. Growth was largely supported by consumer spending. It is expanding at a pace above what U.S. central bank officials regard as the non-inflationary growth rate of 1.8%.
The reading of first quarter economic growth comes at a crucial time as investors digest the potential impacts of the Fed holding interest rates higher for longer.
A £31 billion takeover pursuit and some robust blue-chip updates helped to boost the FTSE 100 index today. Anglo American, whose interests include De Beers and the giant Woodsmith polyhalite project in North Yorkshire, is the target of Australia’s BHP. Meanwhile, shares in Barclays, AstraZeneca and Unilever performed strongly after their first quarter updates.
Global acute repetitive seizures market was valued at USD 2.90 billion in 2023 and is anticipated to generate an estimated revenue of USD 7.94 billion by 2032, with a CAGR of 11.9% from 2024 to 2032.New York, NY, April 25, 2024 (GLOBE NEWSWIRE) -- According to Polaris Market Research, the global acute repetitive seizures market size and share was valued at USD 2.90 billion in 2023 and is anticipated to generate an estimated revenue of USD 7.94 billion by 2032, with a CAGR of 11.9% from 2024 to 2
PITTSBURGH, April 25, 2024--Eaton awarded $26.6M in federal tax credits supporting U.S. manufacturing and workforce training programs advancing clean energy projects
Apple has rejected Spotify's new version of its iOS app with in-app pricing information for users in the European Union, the audio streaming firm said on Thursday. The Swedish company submitted a new version of its app to Apple with basic pricing and website information, which is a minimum requirement under the European Commission's ruling in its music streaming case, it said in a post on X on Wednesday. Spotify said the Cupertino, California based-Apple rejected its update in a response directly sent to the company.
Previously Announced Award for Airship AI’s Acropolis Enterprise Video and Data Management Platform in the FedRAMP Environment Successfully Developed into Additional DOJ Award for Outpost AIREDMOND, Wash., April 25, 2024 (GLOBE NEWSWIRE) -- Airship AI Holdings, Inc. (NASDAQ: AISP) (“Airship AI” or the “Company”), a leader in AI-driven video, sensor, and data management surveillance solutions, has been awarded a multi-million dollar contract to an agency within the Department of Justice (“DOJ”) f
"I’m going through my second childhood," jokes the centenarian in an Instagram video
Conference Call to be Held Thursday, May 9, 2024, at 5:00 p.m. ETESCONDIDO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (“OSS” or the "Company") (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, announced today that the Company will release its first quarter 2024 financial results after the market closes on Thursday, May 9, 2024. A webcast and conference call will be held tha
SANTA CLARA, Calif., April 25, 2024--HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time
Novartis paved the way for radiopharmaceuticals. Now, Big Pharma thinks it can do better — and biotech stocks have soared on a spate of deals.
Renasant Corporation (NASDAQ:RNST) Q1 2024 Earnings Call Transcript April 24, 2024 Renasant Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to the Renasant Corporation 2024 First Quarter Earnings Conference Call. All participants will be in […]
For example, it emerged that our winner had taken £200k from a company owned by a man previously convicted of illegally dumping waste. Or that a government department gave the same company a £400k loan from the state-run Development Bank when Gething was a minister. This is the real-life account of how new First Minister Vaughan Gething grasped the leadership of the Welsh Labour Party just a few weeks ago – and I bet you didn’t know about it.
NEW ORLEANS, April 25, 2024--Veolia North America, the leading provider of environmental solutions in the U.S. and Canada, and the Sewerage and Water Board of New Orleans (SWBNO) have established a groundbreaking partnership to reimagine how the city collects, treats and manages its wastewater, turning the byproducts of wastewater treatment into environmental assets and improving the quality of life in New Orleans. The new partnership will save almost $2 million a year, reduce energy and chemica
VAUGHAN, Ontario, April 25, 2024--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Frontiers in Ophthalmology published statistically significant results from a clinical study evaluating the efficacy and safety of a novel daily nutritional supplement formulated to address the symptoms of dry eyes.1 Bausch + Lomb expects to launch the supplement, which features a proprietary blend of ingredients
AUSTIN, Texas, April 25, 2024--Hyliion Holdings Corp. (NYSE: HYLN) ("Hyliion"), a developer of sustainable electricity-producing technology, and BayoTech, an innovator in hydrogen production, transportation and storage solutions, today announced the signing of a Partnership Agreement (Agreement) aimed at leveraging the expertise of both companies to offer comprehensive power solutions to their existing and future customers. The partnership will allow the companies to introduce their innovative s
MIAMI, FL, April 25, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced that the Company will present two late-breaking abstract presentations at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting, taking place May 9-11, 2024 in New Orleans, LA. The
LOS ANGELES, April 25, 2024 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today announced that its Board of Directors declared a cash dividend on its common stock for the 2024 second quarter of $0.25 per share. The dividend will be paid on May 22, 2024, to stockholders of record as of the close of business on May 6, 2024. In addition, the Board of Directors today approved a new stock repurchase program. Under the new re
Provides MangoRx with entrance into the non-Rx based, nutraceutical product space for sales on both direct-to-consumer online platforms and through retail locations Dallas, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth and hormone replacement therapies is excited to announce that
Phase 1b data in the first 50% of patients reflect the responses seen in animals and may suggest superiority in both safety and efficacy when compared to oral Revlimid®Anticipate FDA alignment and guidance on Phase 2 clinical trials in multiple myeloma (MM) and chronic lymphocytic leukemia (CLL) in 4Q24 PARAMUS, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care therapies with propr